Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
31.67
+0.54 (1.73%)
Dec 20, 2024, 4:00 PM EST - Market closed
Guardant Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Revenue | 692.26 | 563.95 | 449.54 | 373.65 | 286.73 | 214.38 | Upgrade
|
| Revenue Growth (YoY) | 29.20% | 25.45% | 20.31% | 30.32% | 33.75% | 136.52% | Upgrade
|
| Cost of Revenue | 274.72 | 227.05 | 156.33 | 122.91 | 92.54 | 70.72 | Upgrade
|
| Gross Profit | 417.53 | 336.9 | 293.21 | 250.74 | 194.2 | 143.66 | Upgrade
|
| Selling, General & Admin | 504.68 | 451.03 | 463.78 | 398.52 | 299.28 | 139.73 | Upgrade
|
| Research & Development | 341.97 | 365.09 | 368.61 | 263.22 | 149.86 | 86.29 | Upgrade
|
| Operating Expenses | 846.64 | 816.12 | 832.39 | 661.74 | 449.15 | 226.03 | Upgrade
|
| Operating Income | -429.11 | -479.23 | -539.18 | -411 | -254.95 | -82.37 | Upgrade
|
| Interest Expense | -2.58 | -2.58 | -2.58 | -2.58 | -4.77 | -1.18 | Upgrade
|
| Interest & Investment Income | 55.93 | 35.37 | 6.07 | 3.93 | 10.17 | 13.74 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.44 | 2.52 | -99.51 | 0.18 | 3.64 | 0.09 | Upgrade
|
| EBT Excluding Unusual Items | -374.33 | -443.92 | -635.2 | -409.47 | -245.9 | -69.72 | Upgrade
|
| Gain (Loss) on Sale of Investments | -52.03 | 50.66 | -13.05 | - | - | - | Upgrade
|
| Legal Settlements | -83.4 | -83.4 | - | - | - | - | Upgrade
|
| Other Unusual Items | -2.63 | -2.1 | -5.2 | 25 | - | - | Upgrade
|
| Pretax Income | -512.38 | -478.76 | -653.45 | -384.47 | -245.9 | -69.72 | Upgrade
|
| Income Tax Expense | 0.03 | 0.69 | 1.14 | 0.3 | 0.38 | -1.87 | Upgrade
|
| Earnings From Continuing Operations | -512.41 | -479.45 | -654.59 | -384.77 | -246.28 | -67.85 | Upgrade
|
| Minority Interest in Earnings | - | - | - | -20.9 | -7.5 | -7.8 | Upgrade
|
| Net Income | -512.41 | -479.45 | -654.59 | -405.67 | -253.78 | -75.65 | Upgrade
|
| Net Income to Common | -512.41 | -479.45 | -654.59 | -405.67 | -253.78 | -75.65 | Upgrade
|
| Shares Outstanding (Basic) | 121 | 112 | 102 | 101 | 98 | 91 | Upgrade
|
| Shares Outstanding (Diluted) | 121 | 112 | 102 | 101 | 98 | 91 | Upgrade
|
| Shares Change (YoY) | 12.48% | 9.60% | 0.85% | 3.91% | 7.62% | 197.99% | Upgrade
|
| EPS (Basic) | -4.22 | -4.28 | -6.41 | -4.00 | -2.60 | -0.84 | Upgrade
|
| EPS (Diluted) | -4.22 | -4.28 | -6.41 | -4.00 | -2.60 | -0.84 | Upgrade
|
| Free Cash Flow | -274.36 | -345.46 | -386.92 | -284.05 | -140.1 | -65.85 | Upgrade
|
| Free Cash Flow Per Share | -2.26 | -3.08 | -3.79 | -2.80 | -1.44 | -0.73 | Upgrade
|
| Gross Margin | 60.31% | 59.74% | 65.23% | 67.11% | 67.73% | 67.01% | Upgrade
|
| Operating Margin | -61.99% | -84.98% | -119.94% | -110.00% | -88.92% | -38.42% | Upgrade
|
| Profit Margin | -74.02% | -85.02% | -145.61% | -108.57% | -88.51% | -35.29% | Upgrade
|
| Free Cash Flow Margin | -39.63% | -61.26% | -86.07% | -76.02% | -48.86% | -30.72% | Upgrade
|
| EBITDA | -386.31 | -436.34 | -503.22 | -388.73 | -238.89 | -70.96 | Upgrade
|
| EBITDA Margin | -55.80% | -77.37% | -111.94% | -104.03% | -83.31% | -33.10% | Upgrade
|
| D&A For EBITDA | 42.8 | 42.88 | 35.96 | 22.27 | 16.07 | 11.41 | Upgrade
|
| EBIT | -429.11 | -479.23 | -539.18 | -411 | -254.95 | -82.37 | Upgrade
|
| EBIT Margin | -61.99% | -84.98% | -119.94% | -110.00% | -88.92% | -38.42% | Upgrade
|
| Revenue as Reported | 692.26 | 563.95 | 449.54 | 373.65 | 286.73 | 214.38 | Upgrade
|
| Advertising Expenses | - | 2.1 | 8.9 | 2.4 | 1.2 | 1.3 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.